- Home
- PROK vs HIX Comparison
PROK vs HIX Comparison
Compare PROK & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- HIX
- Stock Information
- Founded
- PROK 2015
- HIX 1998
- Country
- PROK United States
- HIX United States
- Employees
- PROK N/A
- HIX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- HIX Finance/Investors Services
- Sector
- PROK Health Care
- HIX Finance
- Exchange
- PROK Nasdaq
- HIX Nasdaq
- Market Cap
- PROK 384.2M
- HIX 384.6M
- IPO Year
- PROK N/A
- HIX N/A
- Fundamental
- Price
- PROK $2.17
- HIX $4.35
- Analyst Decision
- PROK Buy
- HIX
- Analyst Count
- PROK 5
- HIX 0
- Target Price
- PROK $6.25
- HIX N/A
- AVG Volume (30 Days)
- PROK 1.7M
- HIX 449.5K
- Earning Date
- PROK 08-12-2025
- HIX 01-01-0001
- Dividend Yield
- PROK N/A
- HIX 13.14%
- EPS Growth
- PROK N/A
- HIX N/A
- EPS
- PROK N/A
- HIX N/A
- Revenue
- PROK $527,000.00
- HIX N/A
- Revenue This Year
- PROK $265.05
- HIX N/A
- Revenue Next Year
- PROK N/A
- HIX N/A
- P/E Ratio
- PROK N/A
- HIX N/A
- Revenue Growth
- PROK N/A
- HIX N/A
- 52 Week Low
- PROK $0.46
- HIX $4.16
- 52 Week High
- PROK $7.13
- HIX $5.08
- Technical
- Relative Strength Index (RSI)
- PROK 41.52
- HIX 61.76
- Support Level
- PROK $2.23
- HIX $4.27
- Resistance Level
- PROK $2.44
- HIX $4.32
- Average True Range (ATR)
- PROK 0.15
- HIX 0.03
- MACD
- PROK -0.02
- HIX 0.00
- Stochastic Oscillator
- PROK 6.07
- HIX 100.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.